Page last updated: 2024-11-05

periplogenin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

periplogenin: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10574
CHEMBL ID460768
SCHEMBL ID1483841
MeSH IDM0052993

Synonyms (31)

Synonym
unii-b6808p7iy9
b6808p7iy9 ,
514-39-6
desoxostrophanthidin
card-20(22)-enolide, 3,5,14-trihydroxy-, (3-beta,5-beta)-
periplogenin
3-beta,5,14-trihydroxy-5-beta-card-20(22)-enolide
5-beta-card-20(22)-enolide, 3-beta,5,14-trihydroxy-
5-beta-hydroxydigitoxigenin
3-[(3s,5s,8r,9s,10r,13r,14s,17r)-3,5,14-trihydroxy-10,13-dimethyl-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2h-furan-5-one
CHEMBL460768
SCHEMBL1483841
S9168
AKOS015897157
AC-34247
5.beta.-hydroxydigitoxigenin
periplogenin [mi]
(3.beta.,5.beta.)-3,5,14-trihydroxycard-20(22)-enolide
card-20(22)-enolide, 3,5,14-trihydroxy-, (3.beta.,5.beta.)-
3,5,14-trihydroxycard-20(22)-enolide #
3.beta.,5.beta.,14.beta.-trihydroxy-20(22)-cardenolide
QJPCKAJTLHDNCS-FBAXFMHRSA-N
5.beta.-card-20(22)-enolide, 3.beta.,5,14-trihydroxy-
HY-N2414
mfcd01745139
3,5,14-trihydroxycard-20(22)-enolide
DTXSID50965711
CCG-268535
Q27274425
CS-0022615
MS-26510

Research Excerpts

Overview

Piplogenin is a compound extracted from cortex periplocae.

ExcerptReferenceRelevance
"Periplogenin is a compound extracted from cortex periplocae. "( Mechanism of Action of Periplogenin on Nasopharyngeal Carcinoma Based on Network Pharmacology and Experimental Study of Vitamin E Coupled with Periplogenin Self-Assembled Nano-Prodrug for Nasopharyngeal Carcinoma.
Guo, L; Huang, Z; Liang, G; Meng, C; Su, W; Wei, X; Wei, Y; Ye, H, 2020
)
2.31

Toxicity

ExcerptReferenceRelevance
" Its use is associated with adverse effects including cardiotoxicity."( Periplogenin-3-O- -D-glucopyranosyl -(1-->6)- -D-glucopyaranosyl- -(1-->4) -D-cymaropyranoside, isolated from Aegle marmelos protects doxorubicin induced cardiovascular problems and hepatotoxicity in rats.
Kar, A; Panda, S, 2009
)
1.8

Pharmacokinetics

ExcerptReferenceRelevance
" The proposed method was successfully applied to evaluating the pharmacokinetic studies of periplocin and its metabolites (periplocymarin and periplogenin) in rats after a single oral administration of periplocin at 50 mg/kg."( A validated LC-MS/MS assay for the simultaneous determination of periplocin and its two metabolites, periplocymarin and periplogenin in rat plasma: Application to a pharmacokinetic study.
Azietaku, JT; Bo, F; Chang, Y; Dou, T; Gao, X; He, J; Liu, H; Ouyang, H; Tu, Y, 2015
)
0.83
" Using this method, the concentrations of periplocin, PM, PG, PSM and PSN were established after oral administration of Cortex Periplocae extract to rats, and the pharmacokinetic characteristics of periplocin, PM, PG, PSM and PSN were assessed."( Simultaneous determination of periplocin, periplocymarin, periplogenin, periplocoside M and periplocoside N of Cortex Periplocae in rat plasma and its application to a pharmacokinetic study.
Gao, Y; Li, Y; Wang, Q; Wang, S; Wang, W; Wei, M; Wu, J; Wu, S; Yang, W; Yu, X; Yuan, Z; Zhu, M, 2022
)
0.97

Dosage Studied

ExcerptRelevanceReference
" In this study, a sensitive and reliable liquid chromatography-tandem mass spectrometry method was developed and validated to identify and quantify periplocin and its two metabolites in rat tissue after a single dosage of perplocin at 50 mg/kg."( Tissue distribution study of periplocin and its two metabolites in rats by a validated LC-MS/MS method.
Azietaku, JT; Chang, Y; Gao, X; He, J; Liu, H; Ouyang, H; Sun, M; Tang, Z; Wang, M; Zhang, D, 2018
)
0.48
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (3)

Assay IDTitleYearJournalArticle
AID155910Inhibitory activity against the primary liver carcinoma (PLC) cell line PLC/PRF/52002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
AID356599Antiproliferative activity against human HT1080 cells after 72 hrs by MTT assay2003Journal of natural products, Nov, Volume: 66, Issue:11
Constituents of the Vietnamese medicinal plant Streptocaulon juventas and their antiproliferative activity against the human HT-1080 fibrosarcoma cell line.
AID155909Inhibitory activity against colchicine resistant parent primary liver carcinoma (PLC) cell line PLC/PRF/52002Journal of medicinal chemistry, Dec-05, Volume: 45, Issue:25
QSAR evaluation of the Ch'an Su and related bufadienolides against the colchicine-resistant primary liver carcinoma cell line PLC/PRF/5(1).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (22)

TimeframeStudies, This Drug (%)All Drugs %
pre-19904 (18.18)18.7374
1990's1 (4.55)18.2507
2000's4 (18.18)29.6817
2010's9 (40.91)24.3611
2020's4 (18.18)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 19.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index19.59 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index5.13 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (19.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]